Market Cap : 450.59 B | Enterprise Value : 438.5 B | PE Ratio : 24.93 | PB Ratio : 5.89 |
---|
NYSE:JNJ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:JNJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Johnson & Johnson's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $35.795. Johnson & Johnson's 10-Year median PS Ratio is 4.5459. Therefore, the Median PS Value for today is $162.72.
As of today (2022-08-19), Johnson & Johnson's share price is $169.31. Johnson & Johnson's Median PS Value is $162.72. Therefore, Johnson & Johnson's Price to Median PS Value for today is 1.04.
The historical rank and industry rank for Johnson & Johnson's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of Johnson & Johnson was 2.09. The lowest was 0.59. And the median was 1.18.
JNJ's Price-to-Median-PS-Value is ranked worse thanThe historical data trend for Johnson & Johnson's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Johnson & Johnson's Median PS Value, along with its competitors' market caps and Median PS Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Median PS Value distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's Median PS Value falls into.
Johnson & Johnson's Median PS Value for today is calculated as
Median PS Value | = | Revenue per Share (TTM) | * | 10-Year Median PS Ratio |
= | 35.795 | * | 4.5459 | |
= | 162.72 |
10-Year Median PS Ratio is 4.5459.
Johnson & Johnson's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.795.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Johnson & Johnson's Price to Median PS Value for today is calculated as
Price to Median PS Value | = | Share Price | / | Median PS Value |
= | 169.31 | / | 162.72 | |
= | 1.04 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Johnson & Johnson's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Adamczyk Darius | director | 855 S. MINT STREET CHARLOTTE NC 28202 |
Hait William | officer: See Remarks | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Mammen Mathai | officer: EVP, Pharm, R&D | THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 |
Broadhurst Vanessa | officer: EVP, Global Corp Aff. | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Swanson James D. | officer: EVP, Chief Information Officer | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
West Nadja | director | 1915 REXFORD ROAD CHARLOTTE NC 28211 |
Decker Robert J | officer: Controller, CAO | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Joly Hubert | director | C/O BEST BUY CO, INC. 7601 PENN AVENUE SOUTH RICHFIELD MN 55423 |
Weinberger Mark A | director | METLIFE, INC. 200 PARK AVENUE NEW YORK NY 10166 |
Hewson Marillyn A | director | C/O CARPENTER TECHNOLOGY CORPORATION PO BOX 14662 READING PA 19612-4662 |
Mongon Thibaut | officer: Exec VP, WW Chair, Consumer | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Wengel Kathryn E | officer: EVP, Chief GSC Officer | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Wolk Joseph J | officer: Exec VP, CFO | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Mcevoy Ashley | officer: EVP, WW Chair, Medical Devices | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
From GuruFocus
Other Sources
By Zacks 2022-03-21
By Zacks 2022-03-14
By Zacks 2022-03-21
By Zacks 2022-03-14
By Fool 2022-03-25
By Zacks 2022-03-24
By Zacks 2022-04-04
By Zacks 2022-03-14
By Zacks 2022-03-30
By Zacks 2022-04-04
By tipranks.com 2022-03-16
By Fool 2022-03-31
By Zacks 2022-04-06
By Zacks 2022-03-21